We would like to emphasise that our observations are not inconsistent with the recently reported ability of anti‐CCR8 antibodies to reduce tumour growth in syngeneic tumour models in mice, but suggest a re‐interpretation of the mechanism underlying these observations [34]. The gene discussed is CCR8; the disease is neoplasm.